Anlon Healthcare544497Quarterly results
Board approves unaudited Q2 results; auditor's review conclusion unmodified
Board met on Thursday, October 29, 2026 and approved the unaudited standalone and consolidated results for the quarter ended September 30, 2026; the Audit Committee reviewed and recommended them.
By ScoutQuest · · 3 min read
| Line item | Latest | Year ago | YoY | Prev qtr | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 10,560.97 | 5,220.13 | +102% | 8,756.27 | +20.6% |
| Total income | 10,565.50 | 5,222.85 | +102% | 8,762.23 | +20.6% |
| Profit before tax | 2,347.45 | 1,244.68 | +88.6% | 1,365.99 | +71.8% |
| Profit after tax | 1,717.80 | 931.73 | +84.4% | 828.14 | +107% |
| Total comprehensive income | 1,721.42 | 931.73 | +84.8% | 826.25 | +108% |
| Basic EPS | 0.32 | 0.18 | +77.8% | 0.16 | +100% |
- Total income
- Latest 10,565.50; Year ago 5,222.85 (+102%); Prev qtr 8,762.23 (+20.6%)
- Profit after tax
- Latest 1,717.80; Year ago 931.73 (+84.4%); Prev qtr 828.14 (+107%)
- Period
- Quarter Ended 30-09-2026
Auditor's review
Conclusion: Unmodified
- Other Matter: five subsidiaries' unaudited results (total revenue ₹5320.04 lakhs, PAT ₹916.75 lakhs for the quarter) were furnished by management; conclusion relies solely on them.
Notes to the results
- Anlon Healthcare Nigeria Limited has not undertaken transactions, shares not allotted; considering absence of control, it has not been consolidated in the financial statements.
What the board approved
Anlon Healthcare's board met on Thursday, October 29, 2026 and approved the unaudited standalone and consolidated financial results for the quarter ended September 30, 2026 and for the half year from April 01, 2026 to September 30, 2026. The Audit Committee reviewed and recommended them at its meeting held the same day.
Auditor's review conclusion
- The independent auditor, R V D & Co, Chartered Accountants, carried out a review under SRE 2410, which gives moderate assurance and is not an audit opinion.
- On both the standalone and consolidated statements the conclusion is unmodified: nothing has come to the auditor's attention that causes it to believe the statements contain any material misstatement.
- Total tax expense on the standalone statement was 491.78 in the quarter against 312.95 a year earlier.
Standalone results (Rs. in lakhs)
- Revenue from operations: 6,045.46 in the quarter against 5,220.13 in the same quarter a year earlier; 9,143.02 for the half year.
- Total income: 6,048.00 for the quarter.
- Profit/(loss) before tax: 1,296.45 against 1,244.68.
- Profit/(loss) after tax for the period: 804.67 against 931.73; 1,284.38 for the half year.
- Basic and diluted earnings per share: 0.15 each for the quarter, against 0.18 each a year earlier.
Consolidated results (Rs. in lakhs)
- Revenue from operations: 10,560.97 for the quarter; 19,317.24 for the half year.
- Total income: 10,565.50 for the quarter.
- Profit/(loss) after tax for the period: 1,717.80 for the quarter; 2,545.94 for the half year.
- Of the quarterly profit, 1,336.57 is attributable to owners of the company and 381.23 to non-controlling interests.
- Total comprehensive income for the quarter: 1,721.42.
What the consolidated numbers include
- The consolidated statement covers five subsidiaries: Apico Organics Private Limited, Bizotic Lifescience Private Limited, Anlon Medicos Private Limited (formerly Remember India Health Links Private Limited), Anlon Biologics Private Limited and Anlon Medicare Private Limited.
- These five subsidiaries together contributed total revenue (before consolidation adjustments) of ₹5320.04 lakhs and net profit after tax (before consolidation adjustments) of ₹916.75 lakhs for the quarter ended September 30, 2026.
- The company operates as one integrated business segment: manufacturing and sale of Active Pharmaceutical Ingredients (APIs).
Other points in the update
- One investor complaint was received during the second quarter of FY 2026-27 and remains pending as on the reporting date.
- Paid-up equity share capital is shown at Rs. 10,630.30 lakhs as at September 30, 2026 against Rs. 5,315.15 lakhs as at March 31, 2026, and face value per share is printed as Rs. 2.00 against Rs. 10.00 in the older columns of the results table.
How to read it
- The figures are unaudited but have been reviewed, and the review conclusion is clean.
- In the standalone quarter, revenue from operations rose while profit after tax came in below the same quarter last year, with total tax expense higher at 491.78 against 312.95.
- The consolidated numbers are larger than the standalone numbers because the subsidiary businesses are part of that statement, and those five entities contributed 5320.04 lakhs of revenue for the quarter before consolidation adjustments.
Rs. 2,545.94 lakhsProfit/(loss) after tax for the period – consolidated, half year
Profit/(loss) after tax for the period – consolidated, quarterRs. 1,717.80 lakhs
Profit after tax, quarter828.14 (Rs. in Lakhs)
Rs. 10,560.97 lakhs+20.6%
Previous8,756.27 (Rs. in Lakhs)AfterRs. 10,560.97 lakhs
Also from Anlon Healthcare
Anlon Healthcare Q2 FY27 revenue doubles to INR 10,561.0 lacs as it builds integrated pharma platform
30 Oct 2026
NSE, BSE give in-principle approval to 8,05,35,651-share preferential issue via share swap
29 Oct 2026
Anlon Healthcare to hold Q2 & H1 FY27 earnings call on 3 November 2026
26 Oct 2026
More numbers
- Revenue from operations – consolidated, half yearRs. 19,317.24 lakhs
- Profit/(loss) after tax for the period – consolidated, half yearRs. 2,545.94 lakhs
- Revenue from operations – standalone, quarterRs. 6,045.46 lakhs
- Profit/(loss) after tax for the period – standalone, quarterRs. 804.67 lakhs
- Paid-up equity share capital as at 30 September 2026Rs. 10,630.30 lakhs
- Total income, latest quarter10,565.50 (Rs. in Lakhs)
- Total income, year-ago quarter5,222.85 (Rs. in Lakhs)
- Total income, previous quarter8,762.23 (Rs. in Lakhs)
- Total comprehensive income, latest quarter1,721.42 (Rs. in Lakhs)
- Total comprehensive income, year-ago quarter931.73 (Rs. in Lakhs)
- Total comprehensive income, previous quarter826.25 (Rs. in Lakhs)
- Profit after tax, latest quarter1,717.80 (Rs. in Lakhs)
- Profit after tax, year-ago quarter931.73 (Rs. in Lakhs)
- Profit after tax, previous quarter828.14 (Rs. in Lakhs)
- Revenue from operations, latest quarter10,560.97 (Rs. in Lakhs)
- Revenue from operations, year-ago quarter5,220.13 (Rs. in Lakhs)
- Revenue from operations, previous quarter8,756.27 (Rs. in Lakhs)
- Profit before tax, latest quarter2,347.45 (Rs. in Lakhs)
- Profit before tax, year-ago quarter1,244.68 (Rs. in Lakhs)
- Profit before tax, previous quarter1,365.99 (Rs. in Lakhs)
Source: BSE · 29 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.